Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Taylor Slingsby Insider Profile
4 Followers
Brian Taylor Slingsby, Director, Ten Percent Owner at Mineralys Therapeutics, Inc., holds 8.64M shares in Mineralys Therapeutics, Inc. (Ticker: MLYS). Most recently, Brian Taylor Slingsby Sold $550,000 shares of Mineralys Therapeutics, Inc. on Jul 26, 2024 for an estimated value of 7.18M.
Brian Taylor Slingsby Mineralys Therapeutics, Inc. (MLYS)Director, Ten Percent Owner
Mineralys Therapeutics, Inc. (MLYS)
Director, Ten Percent Owner
Ranked #56,853 out of 99,335 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-8.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Brian Taylor Slingsby's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Brian Taylor Slingsby holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 26, 2024 - Today
Return:-4.30%
The most profitable trade made by Brian Taylor Slingsby
Brian Taylor Slingsby's Trading History
List of latest transactions for each holding click on a transaction to see Brian Taylor Slingsby's performance on stock
You May Also Like
Brian Taylor Slingsby insider profile FAQ
What is the percentage of profitable transactions made by Brian Taylor Slingsby?
The percentage of profitable transactions made by Brian Taylor Slingsby is 0%.
What is the average return per transaction made by Brian Taylor Slingsby?
The average return per transaction made by Brian Taylor Slingsby is -8.50%.
What stocks does Brian Taylor Slingsby hold?
Brian Taylor Slingsby holds: MLYS stocks.
What was Brian Taylor Slingsby’s latest transaction?
Brian Taylor Slingsby latest transaction was an Informative Sell of $7.18M.
What was Brian Taylor Slingsby's most profitable transaction?
Brian Taylor Slingsby’s most profitable transaction was an Informative Sell of MLYS stock on July 26, 2024. The return on the trade was -4.30%.
What is Brian Taylor Slingsby's role in Mineralys Therapeutics, Inc.?
Brian Taylor Slingsby's role in Mineralys Therapeutics, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.